Welcome
Support Centre
13 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Validation of the BESSt Formula in eyes undergoing phacoemulsification following keratorefractive surgery
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN34442493
Date ISRCTN assigned28/09/2007
Local reference number(s)N0141187716
Public titleValidation of the BESSt Formula in eyes undergoing phacoemulsification following keratorefractive surgery
Scientific title
AcronymN/A
Disease/condition/study domainEye Diseases: Cataract
Study hypothesisTo assess the feasibility of a randomised controlled trial to assess the accuracy of a formula (BESSt© formula) recently developed to calculate the power of the lens to implant in the eye during cataract surgery in eyes which have previously undergone laser refractive surgery.
Design/methodologyCentrally randomised controlled trial - pilot study
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Any eye undergoing phaco following keratorefractive surgery
2. Any intraocular lens (IOL) model
3. Any type of keratorefractive surgery
4. Patients under the care of Ms Ficker or Mr Stevens
Participants - exclusion criteria1. Children
2. Corneal scarring or opacity
3. Severe dry eyes or ptosis
4. Complicated phaco, presence of a rhexis tear if IOL is implanted in bag
Patient information material
Anticipated start date01/08/2006
Anticipated end date01/05/2007
Status of trialCompleted
Target number of participants30 eyes
Interventions1. BESSt©
2. Hollday
Primary outcome measure(s)1. Patient recruitment rates
2. Rates of loss to follow up in treatment arm
3. Difference between target and achieved manifest refraction following phaci in the two groups
Secondary outcome measure(s)Proportion of eyes with outcomes within +0.25/0.5/0.75/1/1.50/2.0D from the target refraction using the different formulae
Sources of fundingMoorfields Eye Hospital NHS Foundation Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMr Edmondo Borasio
Contact detailsMoorfields Eye Hospital
162 City Road


London
United Kingdom
EC1V 2PD
Contact telephone+44
Contact fax+44
Contact emailedmondoborasio@gmail.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN34442493
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central